-+ 0.00%
-+ 0.00%
-+ 0.00%

Citizens Initiates Coverage On Nasus Pharma with Market Outperform Rating, Announces Price Target of $19

Benzinga·12/18/2025 13:13:07
Listen to the news
Citizens analyst Jason Butler initiates coverage on Nasus Pharma (AMEX:NSRX) with a Market Outperform rating and announces Price Target of $19.